Showing results (91-100 of 118) with videos related to
Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkersJarushka Naidoo, Karisa C Schreck, Wei Fu, et al.Blood Advances|February 7, 2019
MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasNaema Nayyar, Michael D White, Corey M Gill, et al.Neuro-Oncology|January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q Lee, Michael Weller, Joohee Sul, et al.Journal of Medical Internet Research|September 3, 2024
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort StudiesSarah M Goodday, Emma Karlin, Alexa Brooks, et al.Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.Oncotarget|August 8, 2012
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasYuchen Jiao, Patrick J Killela, Zachary J Reitman, et al.International Journal of Radiation Oncology, Biology, Physics|July 4, 2018
The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) PerspectiveRobert H Press, Hui-Kuo G Shu, Hyunsuk Shim, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.The New England Journal of Medicine|June 5, 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaIngo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.Proceedings of the National Academy of Sciences of the United States of America|July 22, 2015
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cordYuxuan Wang, Simeon Springer, Ming Zhang, et al.Pageof 12